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Fentazin (perphenazine), a phenothi-
azine, increases circulating prolactin levels
by inhibiting prolactin inhibiting factor.
(Pearson et al., Trans. Am. Physicns, 1969,
32, 225). Female Sprague-Dawley rats aged
30 days were started on daily subcutaneous
injections either of Fentazin (5 mg/kg body
weight) or vehicle (02% citric acid). Both
groups of animals received DMBA (5 mg
i.v.) when aged 50 days. The in vitro meta-
bolism of [3H]dehydroepiandrosterone and
[3H]testosterone was determined in adeno-
carcinomata subsequently appearing in the
rats.
Adenocarcinomata from the Fentazin
treated animals displayed greater meta-
bolism of testosterone than those from
control animals whereas the transformation
of dehydroepiandrosterone was similar in
both groups. The increase in testosterone
metabolism was largely accounted for by a
significant increase in 5-co-reductase activity.
These results suggest that prolactin may
modify the intracellular environment of
steroid hormones in rat adenocarcinomata.
TRIPLE CHEMOTHERAPY IN ACUTE
NON-LYMPHOCYTIC LEUKAEMIA,
J. J. Fennelly and L. O'Connell, Our Lady's
Hospice, Dublin.
Thirty-two patients with acute non-
lymphocytic leukaemia (22 myeloid, 2 mono-
blastic, 3 myelomonoblastic, 2 promyelocytic,
3 blast crisis) have been treated with com-
bined daunorubincin 1 mg/kg i.v. x 1 cyto-
sine arabinoside 2 mg/kg x 5 and vincristine
1 mg i.v. x 1 in 5-day cycles and followed by
6-mercaptopurine and cyclophosphamide
when remission was induced, with reinduction
at 3-monthly intervals. Sixty per cent of
patients went into full remission, which has
lasted from 6 months to 2 years. Two
patients with acute promyelocytic leukaemia
developed coagulation problems which were
controlled by EACA and then went into full
remission. Two patients with acute mono-
blastic and myelomonoblastic leukaemia
went into full remission on this programme.
One patient who was extremely ill during
induction of remission developed a severe
neuropathy. Alopecia was a problem with
higher dosage of daunorubicin and cardio-
toxicity occurred in 2 patients. Reinduction
at 3-monthly intervals with triple chemo-
therapy was smooth and in our opinion
contributes tothe prolongedremissioninthese
cases. Age group did not significantly affect
remission rate.
FAMILIAL HODGKIN'S DISEASE, J. J.
Fennelly and A. McBride, Our Lady's
Hospice, Dublin.
Three girls in one family developed
nodular sclerosing Hodgkin's disease in 1967,
1970 and 1973 respectively. In addition,
other members have had multiple viral
infections, including infectious mononucleosis
and herpetic infections. An intensive study
of chromosomes HL-A typing, blood groups,
immunoglobulins immunity (DNCB Mantoux
test, lymphoblast transformation) has been
carried out on all siblings (5) and parents and
is presented, in addition to complete studies
of viral antibodies, with emphasis on EB
virus. The triple occurrence in this family
at such time intervals suggests that some
genetic factor, i.e. depressed immunity must
in these cases provide an underlying milieu
in which a viral infection may manifest itself
as Hodgkin's disease.
USE OF THE CARCINOEMBRYONIC
ANTIGEN AND SERUM ENZYME
CHANGES IN THE DETECTION OF
METASTATIC INVOLVEMENT OF
THE LIVER, L. Steele, E. H. Cooper,
A. Munro Neville and M. S. Losowsky,
Department of Cancer Research, University
of Leeds, and Chester Beatty Research
Institute, London, and Department of Medi-
cine, St James's University Hospital, Leeds.
The combination ofestimations ofcarcino-
embryonic antigen (CEA) with certain serum
enzymes (y glutamyl transpeptidase (yGT)
and leucine aminopeptidase (LAP) can
enhance the separation of controls from
patients with primary colorectal cancer and
those with metastatic involvement of the
liver.
yGT contributes to this discrimination in
both the primary and secondary case. The
mean values were: (i) control 13-94 ± 7-65;
(ii) primary 21'65 i 12-20 and (iii) metastatic
139-34 ± 96-22.
On the other hand, the LAP was elevated
only in metastatic involvement of the liver
and did not rise before the yGT exceeded
100 units: (i) control 41-55 ± 9-20; (ii)
primary 40-27 + 14-38 and (iii) metastatic
96-81 + 50-39.